Zimmer Biomet Holdings, Inc., along with its subsidiaries, is a prominent entity in the musculoskeletal healthcare sector, operating across the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company is engaged in designing, manufacturing, and marketing a wide array of orthopaedic reconstructive products, including knee and hip implants, sports medicine and trauma solutions under its S.E.T. product line, as well as specialized spine products that comprise medical devices and surgical instruments. Additionally, Zimmer Biomet produces face and skull reconstruction products, and advanced solutions that stabilize and fixate the bones of the chest, aiding in recovery or reconstruction following open-heart surgery, trauma, or to address deformities. The company also offers dental products, which encompass dental reconstructive implants, prosthetics, regenerative solutions, and innovative robotic surgical tools and bone cement products. These offerings are essential in treating patients with various conditions affecting bones, joints, or supporting soft tissues. Zimmer Biomet serves an extensive range of professionals, including orthopedic surgeons, neurosurgeons, oral surgeons, dentists, and various healthcare distributors and organizations. The operating expenses amount to $4,201,700,000.00 encompassing various operational costs incurred. The company achieved a significant net income of $903,800,000.00 showcasing its strong financial health. The EBITDA is $2,250,900,000.00 a key indicator of the company's operational profitability. The net income ratio is 0.12 reflecting the company's profitability margin. In addition, the cost of revenue for the company is $2,191,200,000.00 showcasing its production and operational expenses. The stock is reasonably priced at $113.11 appealing to a broad range of investors. With a high average trading volume of 1,865,273.00 the stock indicates strong liquidity, making it an attractive option for potential buyers. With a mid-range market capitalization of $22,529,950,340.00 the company is a steady performer in the market. It is a key player in the Medical - Devices industry, contributing significantly to the overall market landscape. As a champion of innovation and growth, it belongs to the Healthcare sector, driving advancements that enhance patient care and treatment pathways.